Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Scientists at Trinity College Dublin have uncovered how cancer cells dodge chemotherapy by entering a "zombie-like" state called premature senescence. Key proteins called IAPs neutralize the cell-killing signals triggered by chemo, letting tumor cells survive and even recruit the immune system to help them recover. The good news? Drugs that block IAPs may be able to eliminate these zombie cells and improve treatment outcomes.
Researchers at Trinity College Dublin have discovered a survival mechanism used by cancer cells: when hit with chemotherapy, some tumor cells don't die — they enter a "zombie-like" state. Published in Science Advances, the study reveals that proteins called Inhibitor of Apoptosis Proteins (IAPs) block the cell-death signals triggered by chemo, allowing cancer cells to enter a state called premature senescence instead of dying.
These senescent cells are anything but harmless. They grow to nearly ten times their normal size, ramp up wound-healing genes, and release inflammatory signals that attract immune cells — essentially tricking the body into nurturing the tumor rather than destroying it. This mirrors a long-observed phenomenon in cancer biology: tumors behaving like "wounds that don't heal."
The team also found that senescent cells are heavily dependent on IAPs to survive, meaning drugs called IAP antagonists can selectively destroy them by reactivating their built-in self-destruct program.
Key Takeaways:
Why it matters: Chemo-resistant tumors are one of oncology's biggest hurdles. This research pinpoints a specific molecular mechanism — and a potential drug target — that could help clinicians eliminate more tumor cells and improve survival rates for cancer patients.
